Botanical species · safety record

Iberis amara

The EFSA Compendium of Botanicals holds 6 constituent measurements for Iberis amara. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Iberis amara L.

6Constituent measurements
0Safety records
4Cited sources
20Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 20 licensed products naming Iberis amara as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Fresh

Source material stated

  • Dried ripe seeds
  • Fresh plant
  • Seed
  • Seed(s)
  • Tincture of the seeds

What the records describe

Constituents measured

  • Calystegine a51
  • Calystegine b31
  • Cucurbitacine e1
  • Glucoiberin1
  • Glucoraphanin1
  • Glucosinolates1

Plant parts

  • Seed3
  • Leaves2
  • Aerial part of plants1

Preparations

  • Solvent extraction4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Cucurbitacine eAerial part of plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
GlucoiberinSeedHPLC with standard detection methodsResolve DOI
GlucoraphaninSeedHPLC with standard detection methodsResolve DOI
Calystegine a5LeavesSolvent extractionGC-MSNo resolvable identifier
Calystegine b3LeavesSolvent extractionGC-MSNo resolvable identifier
GlucosinolatesSeedSolvent extractionGC-MSNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. SACHDEVGUPTA, K., RADKE, CD., RENWICK, JAA. ANTIFEEDANT ACTIVITY OF CUCURBITACINS FROM IBERIS-AMARA AGAINST LARVAE OF PIERIS-RAPAE . Phytochemistry, 1993, vol. 33, no. 6, p. 1385-1388. DOI
  2. Bennett, Richard N., Mellon, Fred A., Kroon, Paul A. Screening crucifer seeds as sources of specific intact glucosinolates using ion-pair high-performance liquid chromatography negative ion electrospray mass spectrometry. Journal of agricultural and food chemistry, 2004, vol. 52, no. 3, p. 428-438.
  3. Fabre, Nicolas., Poinsot, Verena., Debrauwer, Laurent., Vigor, Claire., Tulliez, Jacques., Fouraste, Isabelle., Moulis, Claude. Characterisation of glucosinolates using electrospray ion trap and electrospray quadrupole time-of-flight mass spectrometry . Phytochemical analysis, 2007, vol. 18, no. 4, p. 306-319. DOI
  4. Brock, Andrea., Herzfeld, Tobias., Paschke, Reinhard., Koch, Marcus., Draeger, Birgit. Brassicaceae contain nortropane alkaloids. Phytochemistry (elsevier), 2006, vol. 67, no. 18, p. 2050-2057.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue